Nuvectra Corp. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
1,173.00
418.00
202.00
63,710.00
28,165.00
99,240
Total Accounts Receivable
832.00
651.00
417.00
3,177.00
10,875.00
12,324
Inventories
-
-
-
5,233.00
4,978.00
6,627
Other Current Assets
396.00
335.00
145.00
443.00
1,011.00
1,117
Total Current Assets
2,401.00
1,404.00
764.00
72,563.00
45,029.00
119,308
Net Property, Plant & Equipment
4,224.00
4,680.00
4,469.00
6,317.00
6,219.00
5,213
Intangible Assets
40,699.00
40,454.00
40,165.00
39,896.00
39,610.00
33,491
Other Assets
-
-
-
526.00
245.00
-
Total Assets
47,324.00
46,538.00
45,398.00
119,302.00
91,103.00
158,012
ST Debt & Current Portion LT Debt
-
-
-
-
789.00
Accounts Payable
522.00
807.00
542.00
9,928.00
2,043.00
Other Current Liabilities
1,102.00
1,243.00
7,016.00
6,112.00
13,219.00
Total Current Liabilities
1,624.00
2,050.00
7,558.00
16,040.00
16,051.00
Long-Term Debt
-
-
-
13,744.00
25,886.00
Other Liabilities
640.00
-
-
940.00
993.00
Total Liabilities
2,264.00
2,050.00
7,558.00
30,724.00
42,930.00
Common Equity (Total)
45,060.00
44,488.00
37,840.00
88,578.00
48,173.00
Total Shareholders' Equity
45,060.00
44,488.00
37,840.00
88,578.00
48,173.00
Total Equity
45,060.00
44,488.00
37,840.00
88,578.00
48,173.00
Liabilities & Shareholders' Equity
47,324.00
46,538.00
45,398.00
119,302.00
91,103.00

About Nuvectra

View Profile
Address
5830 Granite Parkway
Plano Texas 75024
United States
Employees -
Website http://www.nuvectramed.com
Updated 07/08/2019
Nuvectra Corp. engages in the development and commercialization of neurostimulation technology platform for treatment of various disorders through stimulation of tissues associated with the nervous systems. It operates through Nuvectra, and NeuroNexus segments. The Nuvectra segmeng is a neurostimulation company committed to helping physicians improve the lives of people with chronic conditions.